Hubbry Logo
Electron transport chainElectron transport chainMain
Open search
Electron transport chain
Community hub
Electron transport chain
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Electron transport chain
Electron transport chain
Electron transport chain
View on Wikipedia
from Wikipedia

An electron transport chain (ETC[1]) is a series of protein complexes and other molecules which transfer electrons from electron donors to electron acceptors via redox reactions (both reduction and oxidation occurring simultaneously) and couples this electron transfer with the transfer of protons (H+ ions) across a membrane. Many of the enzymes in the electron transport chain are embedded within the membrane.

The flow of electrons through the electron transport chain is an exergonic process. The energy from the redox reactions creates an electrochemical proton gradient that drives the synthesis of adenosine triphosphate (ATP). In aerobic respiration, the flow of electrons terminates with molecular oxygen as the final electron acceptor. In anaerobic respiration, other electron acceptors are used, such as sulfate.

In an electron transport chain, the redox reactions are driven by the difference in the Gibbs free energy of reactants and products. The free energy released when a higher-energy electron donor and acceptor convert to lower-energy products, while electrons are transferred from a lower to a higher redox potential, is used by the complexes in the electron transport chain to create an electrochemical gradient of ions. It is this electrochemical gradient that drives the synthesis of ATP via coupling with oxidative phosphorylation with ATP synthase.[2]

In eukaryotic organisms, the electron transport chain, and site of oxidative phosphorylation, is found on the inner mitochondrial membrane. The energy released by reactions of oxygen and reduced compounds such as cytochrome c and (indirectly) NADH and FADH2 is used by the electron transport chain to pump protons into the intermembrane space, generating the electrochemical gradient over the inner mitochondrial membrane. In photosynthetic eukaryotes, the electron transport chain is found on the thylakoid membrane. Here, light energy drives electron transport through a proton pump and the resulting proton gradient causes subsequent synthesis of ATP. In bacteria, the electron transport chain can vary between species but it always constitutes a set of redox reactions that are coupled to the synthesis of ATP through the generation of an electrochemical gradient and oxidative phosphorylation through ATP synthase.[3]

Mitochondrial electron transport chains

[edit]
The electron transport chain in the mitochondrion is the site of oxidative phosphorylation in eukaryotes. It mediates the reaction between NADH or succinate generated in the citric acid cycle and oxygen to power ATP synthase.

Most eukaryotic cells have mitochondria, which produce ATP from reactions of oxygen with products of the citric acid cycle, fatty acid metabolism, and amino acid metabolism. At the inner mitochondrial membrane, electrons from NADH and FADH2 pass through the electron transport chain to oxygen, which provides the energy driving the process as it is reduced to water.[4] The electron transport chain comprises an enzymatic series of electron donors and acceptors. Each electron donor will pass electrons to an acceptor of higher redox potential, which in turn donates these electrons to another acceptor, a process that continues down the series until electrons are passed to oxygen, the terminal electron acceptor in the chain. Each reaction releases energy because a higher-energy donor and acceptor convert to lower-energy products. Via the transferred electrons, this energy is used to generate a proton gradient across the mitochondrial membrane by "pumping" protons into the intermembrane space, producing a state of higher free energy that has the potential to do work. This entire process is called oxidative phosphorylation since ADP is phosphorylated to ATP by using the electrochemical gradient that the redox reactions of the electron transport chain have established driven by energy-releasing reactions of oxygen.[citation needed]

Mitochondrial redox carriers

[edit]

Energy associated with the transfer of electrons down the electron transport chain is used to pump protons from the mitochondrial matrix into the intermembrane space, creating an electrochemical proton gradient (ΔpH) across the inner mitochondrial membrane. This proton gradient is largely but not exclusively responsible for the mitochondrial membrane potential (ΔΨM).[5] It allows ATP synthase to use the flow of H+ through the enzyme back into the matrix to generate ATP from adenosine diphosphate (ADP) and inorganic phosphate. Complex I (NADH coenzyme Q reductase; labeled I) accepts electrons from the Krebs cycle electron carrier nicotinamide adenine dinucleotide (NADH), and passes them to coenzyme Q (ubiquinone; labeled Q), which also receives electrons from Complex II (succinate dehydrogenase; labeled II). Q passes electrons to Complex III (cytochrome bc1 complex; labeled III), which passes them to cytochrome c (cyt c). Cyt c passes electrons to Complex IV (cytochrome c oxidase; labeled IV).[citation needed]

Four membrane-bound complexes have been identified in mitochondria. Each is an extremely complex transmembrane structure that is embedded in the inner membrane. Three of them are proton pumps. The structures are electrically connected by lipid-soluble electron carriers and water-soluble electron carriers. The overall electron transport chain can be summarized as follows:

Flowchart of the respiratory electron transport chain of a mitochondrion. It shows two different entry points – one from the top left corner and another from the bottom – and one "O2" exit point. The long or central chain has a pathway starting at the top left corner with NADH, leading downwards to NADH:ubiquinone oxidoreductase, then leftwards to Ubiquinone, then again to Cytochrome bc1, then to Cytochrome C, then downwards to Cytochrome C oxidase, and then to O2. The second pathway starts at the bottom with Succinate, leading upwards to Succinate dehydrogenase, and then it converges with the central chain at Ubiquinone.

Complex I

[edit]
Further information: Respiratory complex I

In Complex I (NADH ubiquinone oxidoreductase, Type I NADH dehydrogenase, or mitochondrial complex I; EC 1.6.5.3), two electrons are removed from NADH and transferred to a lipid-soluble carrier, ubiquinone (Q). The reduced product, ubiquinol (QH2), freely diffuses within the membrane, and Complex I translocates four protons (H+) across the membrane, thus producing a proton gradient. Complex I is one of the main sites at which premature electron leakage to oxygen occurs, thus being one of the main sites of production of superoxide.[6]

The pathway of electrons is as follows:

NADH is oxidized to NAD+, by reducing flavin mononucleotide to FMNH2 in one two-electron step. FMNH2 is then oxidized in two one-electron steps, through a semiquinone intermediate. Each electron thus transfers from the FMNH2 to an Fe–S cluster, from the Fe-S cluster to ubiquinone (Q). Transfer of the first electron results in the free-radical (semiquinone) form of Q, and transfer of the second electron reduces the semiquinone form to the ubiquinol form, QH2. During this process, four protons are translocated from the mitochondrial matrix to the intermembrane space.[7] As the electrons move through the complex an electron current is produced along the 180 Angstrom width of the complex within the membrane. This current powers the active transport of four protons to the intermembrane space per two electrons from NADH.[8]

Complex II

[edit]

In Complex II (succinate dehydrogenase or succinate-CoQ reductase; EC 1.3.5.1) additional electrons are delivered into the quinone pool (Q) originating from succinate and transferred (via flavin adenine dinucleotide (FAD)) to Q. Complex II consists of four protein subunits: succinate dehydrogenase (SDHA); succinate dehydrogenase [ubiquinone] iron–sulfur subunit mitochondrial (SDHB); succinate dehydrogenase complex subunit C (SDHC); and succinate dehydrogenase complex subunit D (SDHD). Other electron donors (e.g., fatty acids and glycerol 3-phosphate) also direct electrons into Q (via FAD). Complex II is a parallel electron transport pathway to Complex I, but unlike Complex I, no protons are transported to the intermembrane space in this pathway. Therefore, the pathway through Complex II contributes less energy to the overall electron transport chain process.[citation needed]

Complex III

[edit]

In Complex III (cytochrome bc1 complex or CoQH2-cytochrome c reductase; EC 1.10.2.2), the Q-cycle contributes to the proton gradient by an asymmetric absorption/release of protons. Two electrons are removed from QH2 at the QO site and sequentially transferred to two molecules of cytochrome c, a water-soluble electron carrier located within the intermembrane space. The two other electrons sequentially pass across the protein to the Qi site where the quinone part of ubiquinone is reduced to quinol. A proton gradient is formed by one quinol () oxidations at the Qo site to form one quinone () at the Qi site. (In total, four protons are translocated: two protons reduce quinone to quinol and two protons are released from two ubiquinol molecules.)[citation needed]

When electron transfer is reduced (by a high membrane potential or respiratory inhibitors such as antimycin A), Complex III may leak electrons to molecular oxygen, resulting in superoxide formation.

This complex is inhibited by dimercaprol (British Anti-Lewisite, BAL), naphthoquinone and antimycin.

Complex IV

[edit]

In Complex IV (cytochrome c oxidase; EC 1.9.3.1), sometimes called cytochrome AA3, four electrons are removed from four molecules of cytochrome c and transferred to molecular oxygen (O2) and four protons, producing two molecules of water. The complex contains coordinated copper ions and several heme groups. At the same time, eight protons are removed from the mitochondrial matrix (although only four are translocated across the membrane), contributing to the proton gradient. The exact details of proton pumping in Complex IV are still under study.[9] Cyanide is an inhibitor of Complex IV.[citation needed]

Coupling with oxidative phosphorylation

[edit]
Depiction of ATP synthase, the site of oxidative phosphorylation to generate ATP.

According to the chemiosmotic coupling hypothesis, proposed by Nobel Prize in Chemistry winner Peter D. Mitchell, the electron transport chain and oxidative phosphorylation are coupled by a proton gradient across the inner mitochondrial membrane. The efflux of protons from the mitochondrial matrix creates an electrochemical gradient (proton gradient). This gradient is used by the FOF1 ATP synthase complex to make ATP via oxidative phosphorylation. ATP synthase is sometimes described as Complex V of the electron transport chain.[10] The FO component of ATP synthase acts as an ion channel that provides for a proton flux back into the mitochondrial matrix. It is composed of a, b and c subunits. Protons in the inter-membrane space of mitochondria first enter the ATP synthase complex through an a subunit channel. Then protons move to the c subunits.[11] The number of c subunits determines how many protons are required to make the FO turn one full revolution. For example, in humans, there are 8 c subunits, thus 8 protons are required.[12] After c subunits, protons finally enter the matrix through an a subunit channel that opens into the mitochondrial matrix.[11] This reflux releases free energy produced during the generation of the oxidized forms of the electron carriers (NAD+ and Q) with energy provided by O2. The free energy is used to drive ATP synthesis, catalyzed by the F1 component of the complex.[13]
Coupling with oxidative phosphorylation is a key step for ATP production. However, in specific cases, uncoupling the two processes may be biologically useful. The uncoupling protein, thermogenin—present in the inner mitochondrial membrane of brown adipose tissue—provides for an alternative flow of protons back to the inner mitochondrial matrix. Thyroxine is also a natural uncoupler. This alternative flow results in thermogenesis rather than ATP production.[14]

Reverse electron flow

[edit]

Reverse electron flow is the transfer of electrons through the electron transport chain through the reverse redox reactions. Usually requiring a significant amount of energy to be used, this can reduce the oxidized forms of electron donors. For example, NAD+ can be reduced to NADH by Complex I.[15] There are several factors that have been shown to induce reverse electron flow. However, more work needs to be done to confirm this. One example is blockage of ATP synthase, resulting in a build-up of protons and therefore a higher proton-motive force, inducing reverse electron flow.[16]

Prokaryotic electron transport chains

[edit]

In eukaryotes, NADH is the most important electron donor. The associated electron transport chain is NADH → Complex I → Q → Complex III → cytochrome c → Complex IV → O2 where Complexes I, III and IV are proton pumps, while Q and cytochrome c are mobile electron carriers. The electron acceptor for this process is molecular oxygen.

In prokaryotes (bacteria and archaea) the situation is more complicated, because there are several different electron donors and several different electron acceptors. The generalized electron transport chain in bacteria is:

Flowchart combining various respiratory electron transport chains of prokaryotes into one generalized pathway. It shows three "Donor" entry points at the top, and two "Acceptor" exit points at the bottom. The long or central chain has a pathway starting with the top left corner Donor, downwards to Dehydrogenase, then rightwards to Quinone, then to Cytochrome bc complex, then to Cytochrome C, then downwards to Oxidoreductase, and then again to the bottom right corner Acceptor. The top middle Donor converges with the central chain at Quinone, and the top right corner at Cytochrome C; Quinone is also a diverging point, leading downwards to Oxidoreductase, and then again to the bottom middle Acceptor.

Electrons can enter the chain at three levels: at the level of a dehydrogenase, at the level of the quinone pool, or at the level of a mobile cytochrome electron carrier. These levels correspond to successively more positive redox potentials, or to successively decreased potential differences relative to the terminal electron acceptor. In other words, they correspond to successively smaller Gibbs free energy changes for the overall redox reaction.

Individual bacteria use multiple electron transport chains, often simultaneously. Bacteria can use a number of different electron donors, a number of different dehydrogenases, a number of different oxidases and reductases, and a number of different electron acceptors. For example, E. coli (when growing aerobically using glucose and oxygen as an energy source) uses two different NADH dehydrogenases and two different quinol oxidases, for a total of four different electron transport chains operating simultaneously.

A common feature of all electron transport chains is the presence of a proton pump to create an electrochemical gradient over a membrane. Bacterial electron transport chains may contain as many as three proton pumps, like mitochondria, or they may contain two or at least one.

Electron donors

[edit]

In the current biosphere, the most common electron donors are organic molecules. Organisms that use organic molecules as an electron source are called organotrophs. Chemoorganotrophs (animals, fungi, protists) and photolithotrophs (plants and algae) constitute the vast majority of all familiar life forms.

Some prokaryotes can use inorganic matter as an electron source. Such an organism is called a (chemo)lithotroph ("rock-eater"). Inorganic electron donors include hydrogen, carbon monoxide, ammonia, nitrite, sulfur, sulfide, manganese oxide, and ferrous iron. Lithotrophs have been found growing in rock formations thousands of meters below the surface of Earth. Because of their volume of distribution, lithotrophs may actually outnumber organotrophs and phototrophs in our biosphere.

The use of inorganic electron donors such as hydrogen as an energy source is of particular interest in the study of evolution. This type of metabolism must logically have preceded the use of organic molecules and oxygen as an energy source.

Dehydrogenases: equivalents to complexes I and II

[edit]

Bacteria can use several different electron donors. When organic matter is the electron source, the donor may be NADH or succinate, in which case electrons enter the electron transport chain via NADH dehydrogenase (similar to Complex I in mitochondria) or succinate dehydrogenase (similar to Complex II). Other dehydrogenases may be used to process different energy sources: formate dehydrogenase, lactate dehydrogenase, glyceraldehyde-3-phosphate dehydrogenase, H2 dehydrogenase (hydrogenase), electron transport chain. Some dehydrogenases are also proton pumps, while others funnel electrons into the quinone pool. Most dehydrogenases show induced expression in the bacterial cell in response to metabolic needs triggered by the environment in which the cells grow. In the case of lactate dehydrogenase in E. coli, the enzyme is used aerobically and in combination with other dehydrogenases. It is inducible and is expressed when the concentration of DL-lactate in the cell is high.[citation needed]

Quinone carriers

[edit]

Quinones are mobile, lipid-soluble carriers that shuttle electrons (and protons) between large, relatively immobile macromolecular complexes embedded in the membrane. Bacteria use ubiquinone (Coenzyme Q, the same quinone that mitochondria use) and related quinones such as menaquinone (Vitamin K2). Archaea in the genus Sulfolobus use caldariellaquinone.[17] The use of different quinones is due to slight changes in redox potentials caused by changes in structure. The change in redox potentials of these quinones may be suited to changes in the electron acceptors or variations of redox potentials in bacterial complexes.[18]

Proton pumps

[edit]

A proton pump is any process that creates a proton gradient across a membrane. Protons can be physically moved across a membrane, as seen in mitochondrial Complexes I and IV. The same effect can be produced by moving electrons in the opposite direction. The result is the disappearance of a proton from the cytoplasm and the appearance of a proton in the periplasm. Mitochondrial Complex III is this second type of proton pump, which is mediated by a quinone (the Q cycle).

Some dehydrogenases are proton pumps, while others are not. Most oxidases and reductases are proton pumps, but some are not. Cytochrome bc1 is a proton pump found in many, but not all, bacteria (not in E. coli). As the name implies, bacterial bc1 is similar to mitochondrial bc1 (Complex III).

Cytochrome electron carriers

[edit]

Cytochromes are proteins that contain iron. They are found in two very different environments.

Some cytochromes are water-soluble carriers that shuttle electrons to and from large, immobile macromolecular structures imbedded in the membrane. The mobile cytochrome electron carrier in mitochondria is cytochrome c. Bacteria use a number of different mobile cytochrome electron carriers.

Other cytochromes are found within macromolecules such as Complex III and Complex IV. They also function as electron carriers, but in a very different, intramolecular, solid-state environment.

Electrons may enter an electron transport chain at the level of a mobile cytochrome or quinone carrier. For example, electrons from inorganic electron donors (nitrite, ferrous iron, electron transport chain) enter the electron transport chain at the cytochrome level. When electrons enter at a redox level greater than NADH, the electron transport chain must operate in reverse to produce this necessary, higher-energy molecule.

It has been observed that inter-protein electron transport between cytochromes c and c1 (complex III) depends on pH and the presence of oxygen, suggesting that protons and superoxide may act as redox mediators in the long-distance electron transport process through the aqueous solution.[19]

Electron acceptors and terminal oxidase/reductase

[edit]

As there are a number of different electron donors (organic matter in organotrophs, inorganic matter in lithotrophs), there are a number of different electron acceptors, both organic and inorganic. As with other steps of the ETC, an enzyme is required to help with the process.

If oxygen is available, it is most often used as the terminal electron acceptor in aerobic bacteria and facultative anaerobes. An oxidase reduces the O2 to water while oxidizing something else. In mitochondria, the terminal membrane complex (Complex IV) is cytochrome oxidase, which oxidizes the cytochrome. Aerobic bacteria use a number of different terminal oxidases. For example, E. coli (a facultative anaerobe) does not have a cytochrome oxidase or a bc1 complex. Under aerobic conditions, it uses two different terminal quinol oxidases (both proton pumps) to reduce oxygen to water.

Bacterial terminal oxidases can be split into classes according to the molecules act as terminal electron acceptors. Class I oxidases are cytochrome oxidases and use oxygen as the terminal electron acceptor. Class II oxidases are quinol oxidases and can use a variety of terminal electron acceptors. Both of these classes can be subdivided into categories based on what redox-active components they contain. E.g. Heme aa3 Class 1 terminal oxidases are much more efficient than Class 2 terminal oxidases.[2]

Mostly in anaerobic environments different electron acceptors are used, including nitrate, nitrite, ferric iron, sulfate, carbon dioxide, and small organic molecules such as fumarate. When bacteria grow in anaerobic environments, the terminal electron acceptor is reduced by an enzyme called a reductase. E. coli can use fumarate reductase, nitrate reductase, nitrite reductase, DMSO reductase, or trimethylamine-N-oxide reductase, depending on the availability of these acceptors in the environment.

Most terminal oxidases and reductases are inducible. They are synthesized by the organism as needed, in response to specific environmental conditions.

Photosynthetic

[edit]
Further information: Light-dependent reaction and Photosynthetic reaction center
Photosynthetic electron transport chain of the thylakoid membrane.

In oxidative phosphorylation, electrons are transferred from an electron donor such as NADH to an acceptor such as O2 through an electron transport chain, releasing energy. In photophosphorylation, the energy of sunlight is used to create a high-energy electron donor which can subsequently reduce oxidized components and couple to ATP synthesis via proton translocation by the electron transport chain.[9]

Photosynthetic electron transport chains, like the mitochondrial chain, can be considered as a special case of the bacterial systems. They use mobile, lipid-soluble quinone carriers (phylloquinone and plastoquinone) and mobile, water-soluble carriers (cytochromes). They also contain a proton pump. The proton pump in all photosynthetic chains resembles mitochondrial Complex III. The commonly held theory of symbiogenesis proposes that both organelles descended from bacteria.

See also

[edit]

References

[edit]

Further reading

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Electron transport chain

View on Grokipedia
from Grokipedia
The electron transport chain (ETC), also known as the respiratory chain, is a series of membrane-bound protein complexes and mobile carriers that transfer high-energy electrons derived from NADH and FADH₂ to molecular oxygen (O₂), the terminal , while simultaneously pumping protons across the to establish an essential for ATP production via . This process occurs primarily in the mitochondria of eukaryotic cells and represents the final stage of aerobic , efficiently converting the energy from nutrient breakdown into usable ATP, with approximately 30–32 molecules of ATP generated per glucose molecule oxidized. In prokaryotes, a similar ETC operates in the plasma membrane, and analogous systems exist in chloroplasts for . The ETC comprises four large protein complexes (I–IV), along with the lipid-soluble carrier ubiquinone (coenzyme Q) and the water-soluble , all embedded in or associated with the . Complex I () initiates the chain by accepting electrons from NADH (produced in the and ), passing them through iron-sulfur clusters and (FMN) to reduce ubiquinone while translocating four protons per two electrons. Complex II (), the only complex not pumping protons directly, feeds electrons from FADH₂ (generated in the ) into ubiquinone without contributing to the initial proton gradient. Electrons then move via reduced ubiquinone to Complex III (cytochrome bc₁ complex), which uses the Q-cycle mechanism to transfer them to while pumping four additional protons. Finally, Complex IV () accepts electrons from , reduces O₂ to water, and pumps two more protons, completing the chain and preventing electron leakage that could generate harmful (ROS). Beyond ATP synthesis, the ETC plays critical roles in cellular , including ROS production as a (primarily at Complexes I and III), which serves as signaling molecules but can contribute to , aging, and diseases like Parkinson's when dysregulated. Recent structural studies, including cryo-electron microscopy of supercomplexes (e.g., I₁III₂IV₁), have revealed how these assemblies enhance efficiency through substrate channeling and stabilization by lipids, underscoring the ETC's evolutionary optimization for energy conservation. Disruptions in ETC function, such as mutations in complex subunits, are implicated in mitochondrial disorders, highlighting its indispensability for aerobic life.

Introduction

Definition and biological role

The electron transport chain (ETC) is a series of multi-protein complexes embedded in cellular membranes that catalyze sequential reactions, transferring electrons from donor molecules to acceptor molecules while coupling this process to proton translocation across the membrane. In eukaryotic cells, the ETC resides in the ; in prokaryotes, it is located in the plasma membrane; and in photosynthetic organisms, it occurs in the membrane of chloroplasts. This conserved mechanism underpins in respiration and in , enabling efficient energy conversion across diverse life forms. The primary biological role of the ETC is to generate a proton motive force—an () across the membrane—through proton pumping driven by exergonic electron transfers, which powers ATP synthesis via . In aerobic respiration, electrons derived from NADH and FADH₂ (produced in , the , and fatty acid oxidation) flow through the chain to oxygen as the terminal acceptor, yielding and facilitating the production of approximately 30–32 ATP molecules per glucose molecule oxidized. The overall reaction for the mitochondrial ETC can be summarized as:
\ceNADH+1/2O2+H+−>NAD++H2O\ce{NADH + 1/2 O2 + H+ -> NAD+ + H2O}
(with associated proton pumping omitted for simplicity). In photosynthesis, electrons originate from (split by light energy) and are transferred via to NADP⁺, producing NADPH and oxygen, while the proton gradient drives ATP formation essential for carbon fixation. This universal process is vital for cellular energy homeostasis, as disruptions in the ETC can impair ATP production and lead to metabolic disorders, underscoring its evolutionary conservation from bacteria to higher eukaryotes.

Historical background

The discovery of the electron transport chain (ETC) emerged from early 20th-century studies on cellular respiration. In the 1920s, Otto Warburg investigated oxygen consumption in living cells using manometric techniques, revealing that respiration involves an iron-containing enzyme that facilitates atmospheric oxygen reduction, for which he received the 1931 Nobel Prize in Physiology or Medicine. Concurrently, David Keilin identified cytochromes as key respiratory pigments in 1925, observing their characteristic absorption bands in yeast, insects, and vertebrates, establishing them as ubiquitous components of aerobic respiration. In the 1940s and , advances in mitochondrial isolation enabled fractionation and component identification. and colleagues developed methods to disrupt mitochondria into functional assemblies, isolating the "cyclophorase" system in 1951 that integrated the with . Britton Chance applied rapid-mixing to elucidate cytochrome kinetics, demonstrating sequential reactions in the respiratory chain during the . The role of quinones was clarified with the 1957 discovery of ubiquinone (coenzyme Q) by Frederick L. Crane, , and associates, who isolated it from beef heart mitochondria as a lipid-soluble electron carrier essential for NADH and succinate oxidation. Efraim Racker's group isolated the F1 portion of from mitochondria in 1960, reconstituting it into vesicles to confirm its role in ATP synthesis. Peter Mitchell proposed the chemiosmotic hypothesis in 1961, positing that ETC-driven proton translocation across the generates an powering ATP synthesis, a concept validated over the next decade and awarded the 1978 . The 1970s and 1980s saw structural insights through and early ; for instance, spectroscopic studies in the 1970s and 1980s mapped electron pathways in Complex I (NADH:ubiquinone ). Recent decades have benefited from cryo-electron microscopy (cryo-EM) for high-resolution structures. Judy Hirst's laboratory determined the near-atomic structure of mammalian Complex I in 2016, revealing its L-shaped architecture and proton-pumping mechanism. In the 2020s, single-molecule techniques have provided dynamic views; for example, tracking of bacterial outer-membrane in 2021 illuminated protein diffusion and rates in respiratory chains. These milestones continue to refine our understanding of ETC assembly and function.

General principles

Redox carriers and electron transfer

The electron transport chain (ETC) relies on a series of carriers that facilitate the transfer of electrons from high-energy donors like NADH to the terminal acceptor oxygen. These carriers are prosthetic groups embedded within membrane-bound protein complexes or mobile within the . Key types include flavins such as (FMN) and (FAD), which accept two electrons and two protons from substrates like NADH or succinate, forming semiquinone intermediates before passing electrons singly. Iron-sulfur (Fe-S) clusters, consisting of 2Fe-2S or 4Fe-4S configurations, serve as one-electron carriers with variable redox potentials tuned to sequential steps in the chain. groups in (b, c, a types) coordinate iron atoms that cycle between Fe³⁺ and Fe²⁺ states, enabling one-electron transfers, while centers in the terminal oxidase handle electron delivery to O₂. Quinones, particularly ubiquinone (coenzyme Q), act as lipid-soluble mobile carriers that shuttle two electrons and protons between complexes, cycling between oxidized ubiquinone and reduced forms. Electron transfer in the ETC proceeds sequentially through these carriers in a downhill gradient, ensuring exergonic flow. NADH donates two electrons to FMN in Complex I via a one-electron semiquinone step, followed by transfers to Fe-S clusters and then to ubiquinone, which accepts two electrons to form . diffuses to the next complex, where it donates electrons—one via an Fe-S cluster to a , and the other through a bifurcated path involving additional hemes. , another mobile one-electron carrier, relays electrons to centers and hemes in the terminal , reducing O₂ to H₂O. This process involves both one- and two-electron steps, with carriers insulated by protein scaffolds to direct flow and prevent leakage, often via quantum tunneling across short distances up to 2 nm. The overall gradient spans from the low potential of NADH/NAD⁺ (E°' ≈ -320 mV) to the high potential of O₂/H₂O (E°' ≈ +820 mV), driving irreversible electron flow. The difference (ΔE) between and donor dictates the feasibility and yield of each transfer, calculated as ΔE = E°'_acceptor - E°'_donor. For the full NADH to O₂ span, ΔE ≈ 1.14 V, making the reaction highly favorable. The associated standard free energy change is given by ΔG°' = -nFΔE, where n is the number of electrons transferred (typically 2 for NADH), and F is the (96.485 kJ/mol/V). This yields ΔG°' ≈ -220 kJ/mol for NADH oxidation, releasing in discrete steps to avoid dissipation as . In mitochondrial systems, this couples to proton translocation, with approximately 10 protons pumped across the per NADH oxidized—4 at Complex I, 4 at Complex III, and 2 at Complex IV—establishing the proton motive force. A specialized mechanism amplifying proton translocation occurs in Complex III via the Q-cycle, a two-step process of quinone oxidation and reduction. In the first step, at the Qo site donates one to the Rieske Fe-S (leading to ) and the other to a low-potential , releasing two protons to the . The second reduces another at the Qi site, taking up two protons from the matrix to form semiquinol, which in a subsequent cycle fully reduces to . This bifurcation effectively translocates 4 H⁺ per 2 transferred (beyond scalar protons), doubling the proton/ compared to linear transfer. The Q-cycle thus enhances bioenergetic efficiency without additional energy input.

Proton translocation and chemiosmosis

Proton translocation in the electron transport chain occurs through two primary mechanisms: vectorial transport driven by conformational changes in membrane-bound complexes and redox-linked scalar proton release or uptake associated with chemistry. In complexes such as Complex I, induces long-range conformational changes that propagate across the protein, facilitating the active pumping of protons from to the via dedicated proton channels. This vectorial mechanism ensures that proton movement is tightly coupled to the reactions without direct scalar release. In contrast, redox-linked translocation, exemplified by the Q-cycle in Complex III, involves the scalar protons liberated or consumed during the reduction and oxidation of at the quinone-binding sites, contributing to net proton displacement across the membrane. The primary sites of proton pumping in the mitochondrial electron transport chain are Complexes I, III, and IV, where from NADH ultimately results in the translocation of 10 protons per two electrons (H⁺/2e⁻) into the . This collective pumping establishes an that stores the energy derived from electron flow. Complex II does not contribute to proton pumping, as its role is limited to without associated translocation. The chemiosmotic theory, proposed by Peter Mitchell, posits that the proton gradient generated by these translocation events forms a proton motive force (Δp) comprising a (Δψ) and a gradient (ΔpH), which drives ATP synthesis through indirect osmotic coupling rather than direct chemical intermediates. This delocalized mechanism allows the gradient to power processes across the membrane without requiring physical linkage between electron transport and phosphorylation sites. The proton motive force is quantitatively expressed as: Δp=Δψ−2.303RTFΔpH\Delta p = \Delta \psi - 2.303 \frac{RT}{F} \Delta \mathrm{pH} where Δp and Δψ are in millivolts, R is the gas constant, T is temperature in Kelvin, F is the Faraday constant, and ΔpH is the difference between internal and external pH (positive when the matrix is more alkaline). In mitochondria, the membrane potential component (Δψ) typically ranges from 150 to 200 mV, negative inside relative to the intermembrane space, reflecting the high energetic barrier protons must overcome to re-enter the matrix. In prokaryotes, this gradient also maintains cytoplasmic pH homeostasis by counteracting environmental acidity through proton influx.

Mitochondrial electron transport chain

Complex I: NADH:ubiquinone oxidoreductase

Complex I, also known as NADH:ubiquinone oxidoreductase, serves as the entry point for electrons from NADH into the mitochondrial electron transport chain, linking catabolic pathways like the tricarboxylic acid cycle to . It catalyzes the transfer of two electrons from NADH to ubiquinone while translocating protons across the , thereby contributing to the essential for ATP synthesis. The enzyme exhibits an L-shaped architecture, with a hydrophilic peripheral arm projecting into the mitochondrial matrix and a hydrophobic membrane arm integrated into the lipid bilayer. In mammalian mitochondria, Complex I consists of 45 subunits totaling approximately 1 MDa, including 14 conserved core subunits critical for electron transfer and proton pumping—seven of which (ND1–ND6 and ND4L) are encoded by mitochondrial DNA, while the remainder are nuclear-encoded. The peripheral arm, primarily composed of nuclear-encoded subunits, accommodates the NADH oxidation site, a flavin mononucleotide (FMN) cofactor, and eight iron-sulfur (Fe-S) clusters arranged in a linear chain. The membrane arm, dominated by mitochondrially encoded subunits, harbors the ubiquinone (Q) binding pocket and four putative proton channels formed by antiporter-like structures in ND2, ND4, and ND5. High-resolution cryo-electron microscopy structures have elucidated these features, revealing intricate subunit interfaces and cofactor positions. Complex I oxidizes NADH to NAD⁺ in the matrix, reducing ubiquinone to (QH₂) at the domain and pumping four protons (4 H⁺/2 e⁻) from the matrix to the . This process establishes a proton motive force without net consumption of matrix protons beyond the reaction stoichiometry. The balanced equation is: NADH+[Q](/page/Q)+5Hmatrix+→NAD++QH2+4Hintermembrane+\text{NADH} + \text{[Q](/page/Q)} + 5\text{H}^+_\text{matrix} \to \text{NAD}^+ + \text{QH}_2 + 4\text{H}^+_\text{intermembrane} Electrons flow sequentially from NADH to FMN, through the eight Fe-S clusters (seven participating in transfer, one structural), and finally to , with midpoint potentials increasing from approximately −320 mV (NADH/NAD⁺) to +90 mV (/QH₂) to drive the exergonic transfer. Proton pumping is coupled to Q reduction via a mechanism involving conformational rearrangements that propagate as an electrostatic "wave" across the membrane arm. Reduction of Q induces loop movements in the Q-binding cavity, tilting transmembrane helices in ND1 and rotating the ND6 subunit, which in turn facilitates proton release through coordinated water networks and charged residues in the antiporter subunits. This indirect coupling avoids short-circuiting the redox reaction while ensuring efficient energy transduction. Beyond the core subunits, approximately 31 accessory proteins provide structural stability, facilitate biogenesis via dedicated assembly factors, and modulate activity under physiological stress. Mutations in Complex I genes, particularly in core subunits like NDUFS1 or mtDNA-encoded ND genes, disrupt assembly or function and are implicated in mitochondrial diseases, including neurodegenerative conditions such as .

Complex II: Succinate:ubiquinone oxidoreductase

Complex II, also known as or , is a heterotetrameric complex embedded in the , consisting of four nuclear-encoded subunits: SDHA, SDHB, SDHC, and SDHD. The SDHA subunit, a , binds (FAD) at its and catalyzes the oxidation of succinate to fumarate, while SDHB serves as the iron-sulfur protein subunit containing three iron-sulfur clusters ([2Fe-2S], [4Fe-4S], and [3Fe-4S]) that facilitate . The membrane-anchoring subunits SDHC and SDHD form a heterodimer that harbors the ubiquinone-binding site at their interface, but unlike other respiratory complexes, Complex II lacks proton-translocating channels or membrane-spanning helices dedicated to pumping. In its primary function, Complex II links the tricarboxylic acid (TCA) cycle to the electron transport chain by oxidizing succinate to fumarate in the TCA cycle while reducing ubiquinone (Q) to ubiquinol (QH2) in the respiratory chain, serving as a dual-role enzyme without net proton translocation across the membrane.01789-1/fulltext) The overall reaction is: Succinate+Q→Fumarate+QH2\text{Succinate} + \text{Q} \rightarrow \text{Fumarate} + \text{QH}_2 This process bypasses Complex I, delivering electrons directly to the ubiquinone pool and subsequently to Complex III, resulting in a lower ATP yield of approximately 1.5 ATP per pair of electrons compared to 2.5 ATP from NADH oxidation via Complex I, due to fewer protons pumped downstream. The redox potentials are tuned for efficient electron transfer, with the succinate/fumarate couple at E°' = +30 mV and the ubiquinone/ubiquinol couple at approximately +90 mV, ensuring thermodynamically favorable reduction of Q. A unique aspect of Complex II is its exclusive position as the only TCA cycle enzyme that directly participates in the electron transport chain, integrating carbon with respiration.01789-1/fulltext) Germline mutations in the SDH subunit genes (SDHA, SDHB, SDHC, SDHD) are associated with hereditary paraganglioma-pheochromocytoma syndromes, where impaired Complex II activity disrupts succinate and stabilizes hypoxia-inducible factors, promoting tumorigenesis.

Complex III: Ubiquinol:cytochrome c oxidoreductase

Complex III, also known as ubiquinol:cytochrome c oxidoreductase or the cytochrome bc1 complex, is a dimeric embedded in the . Each consists of 11 subunits in mammalian mitochondria, including three core redox-active subunits: (encoded by mtDNA), cytochrome c1, and the Rieske iron-sulfur protein (RISP), along with eight additional nuclear-encoded subunits that provide structural stability. The dimer formation, with each featuring four metal centers—hemes b_H and b_L in , heme c1 in cytochrome c1, and a [2Fe-2S] cluster in RISP—facilitates efficient and is essential for the enzyme's stability and function within respiratory supercomplexes. The primary function of Complex III is to oxidize (QH₂) at the Qo site on the side and transfer electrons to , while simultaneously translocating protons across the to contribute to the proton motive . This process involves bifurcating the two electrons from QH₂: one follows the high-potential chain through the RISP [2Fe-2S] cluster to heme c1 and then to , while the other traverses the low-potential chain via hemes b_L and b_H to reduce ubiquinone (Q) at the Qi site on the matrix side. Through this mechanism, Complex III achieves a proton-to-electron of 4 H⁺ translocated per 2 electrons transferred, amplifying the essential for ATP synthesis. The Q-cycle is the hallmark mechanism of Complex III, enabling proton amplification by coupling quinol oxidation and quinone reduction in a cyclic manner. At the Qo site, the first QH₂ molecule binds and undergoes oxidation: one electron is transferred to the RISP [2Fe-2S] cluster (the rate-limiting step, with a timescale of approximately 770 µs), reducing it and leading to the formation of a transient, unstable semiquinone anion (SQ⁻, with low steady-state occupancy around 0.01); this electron then passes to heme c1 and , releasing two protons into the . The second electron from the semiquinone reduces heme b_L, which relays it to heme b_H and ultimately to a ubiquinone at the Qi site, forming a semiquinone intermediate. A second QH₂ oxidation at Qo repeats the process, providing the second electron to fully reduce the Qi semiquinone to QH₂, taking up two protons from the matrix. This bifurcation and recycling ensure that two molecules are reduced per net QH₂ oxidized, without net consumption at Qi. The net reaction catalyzed by Complex III, encompassing one full Q-cycle, is: QH2+2 cyt c3++2 Hmatrix+→Q+2 cyt c2++4 Hintermembrane+\mathrm{QH_2 + 2\ cyt\ c^{3+} + 2\ H^+_{matrix} \to Q + 2\ cyt\ c^{2+} + 4\ H^+_{intermembrane}} This equation reflects the overall electron transfer from ubiquinol to two molecules of oxidized cytochrome c, with enhanced proton release due to the Q-cycle. Unique aspects of Complex III include its two distinct quinone-binding sites: the Qo site, which accommodates stigmatellin binding to inhibit quinol oxidation near the RISP cluster, and the Qi site, targeted by antimycin to block electron transfer from heme b_H. The dimeric architecture not only supports intra-monomer electron transfer (with edge-to-edge distances of about 7-10 Å between hemes) but is also crucial for assembly into supercomplexes with Complexes I and IV, which stabilize the respiratory chain and optimize electron flux while minimizing reactive oxygen species production. The mobility of the RISP extrinsic domain further enables conformational changes essential for Qo site access and efficient bifurcation during the Q-cycle.

Complex IV: Cytochrome c oxidase

Complex IV, also known as , is the terminal of the mitochondrial electron transport chain in eukaryotic cells, consisting of 13 to 14 subunits in mammalian forms, with a catalytic core formed by three mitochondrially encoded subunits (MT-CO1, MT-CO2, and MT-CO3) and the rest as nuclear-encoded supernumerary subunits that stabilize the structure and regulate activity. The MT-CO1 subunit houses heme a and the binuclear center (heme a3 coordinated to CuB), while MT-CO2 contains the CuA binuclear center, and assembly requires specific chaperones for insertion of these metal cofactors into the membrane-embedded complex. These supernumerary subunits, such as COX4 and COX5, form a supramolecular assembly that positions the for efficient electron transfer from cytochrome c and proton translocation. The primary function of is to catalyze the four-electron reduction of molecular oxygen to two molecules of , utilizing electrons from four reduced cytochrome c molecules, while contributing to the proton motive force by translocating protons across the . This reaction consumes four protons from for scalar chemistry and pumps an additional four protons to the per oxygen reduced, though the pumped proton per two electrons (2-4 H+/2e-) has been debated, with experimental evidence supporting a total of four vectorial protons per O2 alongside the scalar protons. The overall balanced equation is: 4 \cecyt c2++\ceO2+8\ceH+matrix→4 \cecyt c3++2\ceH2O+4\ceH+intermembrane4 \ \ce{cyt \ c^{2+}} + \ce{O2} + 8 \ce{H+_{matrix}} \rightarrow 4 \ \ce{cyt \ c^{3+}} + 2 \ce{H2O} + 4 \ce{H+_{intermembrane}} This process ensures complete reduction of O2 without releasing harmful intermediates and links exergonic electron transfer to energy conservation via the proton gradient. The catalytic mechanism involves sequential electron transfer from reduced cytochrome c docked at the extramembranous domain of subunit MT-CO2 to the CuA center, which relays electrons through heme a in MT-CO1 to the binuclear center (heme a3-CuB), where O2 binds to ferrous heme a3 and undergoes four-electron reduction with concomitant cleavage of the O-O bond to form water. Proton loading sites and channels, including the D-pathway in MT-CO1, facilitate both chemical proton uptake for water formation and pumped proton ejection, with the redox-driven conformational changes at the binuclear center ensuring vectorial transport without back-leakage. This tightly coupled electron-proton transfer prevents reactive oxygen species formation during O2 activation. Cytochrome c oxidase activity is allosterically regulated by the ATP/ADP ratio, where ATP binds to nuclear-encoded subunits like COX3 to inhibit and respiration when cellular energy is high, while ADP relieves this inhibition to accelerate turnover. The enzyme is reversibly inhibited by (NO) at nanomolar concentrations, which competitively binds the binuclear center with O2 to modulate mitochondrial respiration in response to signaling, and by (CO), which similarly targets the reduced heme a3 to suppress activity. In brown adipose tissue, supports non-shivering by maintaining high electron flux rates that, coupled with uncoupling protein 1, dissipate the proton gradient as heat rather than ATP synthesis.

Mobile electron carriers: Ubiquinone and cytochrome c

Ubiquinone, also known as coenzyme Q or CoQ, is a lipid-soluble embedded in the that serves as a mobile carrier in the electron transport chain (ETC). It consists of a redox-active ring attached to a polyisoprenoid tail, which in humans comprises 10 units (CoQ10), conferring hydrophobicity and enabling within the membrane lipid bilayer. Ubiquinone cycles between its oxidized form (Q) and reduced form (QH2, ) as it accepts two electrons and two protons from upstream complexes, such as Complex I or II, and donates them to Complex III. This two-electron transfer is governed by the reaction: Q+2H++2e−⇌QH2\text{Q} + 2\text{H}^+ + 2\text{e}^- \rightleftharpoons \text{QH}_2 with a standard (E°') of +90 mV at 7. The ubiquinone pool in the inner maintains a high local concentration, approximately 10-fold greater than that of the respiratory complexes, ensuring rapid and efficient without significant limitations during steady-state respiration. This large pool behaves as a homogeneous reservoir, allowing electrons from multiple dehydrogenases to converge and distribute to downstream acceptors. In , the isoprenoid tail is typically shorter, with 9 units (CoQ9), reflecting species-specific variations in biosynthesis that do not substantially alter its ETC function. Beyond electron shuttling between the Q-binding sites of Complexes I, II, and III, reduced (QH2) exhibits properties by donating electrons to neutralize , thereby protecting lipids from peroxidation. Cytochrome c is a small, water-soluble protein that functions as a one-electron carrier in the mitochondrial ETC, diffusing freely within the to shuttle electrons from Complex III to Complex IV. It has a molecular weight of approximately 12 kDa and contains a covalently bound heme c group, where the iron atom cycles between Fe3+ (oxidized, ferricytochrome c) and Fe2+ (reduced, ferrocytochrome c) states, with a midpoint of about +250 mV. The protein's compact structure, featuring lysine-rich surfaces, facilitates electrostatic interactions with the membrane-associated complexes and anionic phospholipids like , optimizing docking and rates. Maintaining a concentration of around 10 μM in the , cytochrome c ensures kinetic efficiency in electron delivery, supporting maximal respiratory flux under physiological conditions. In pathological contexts, such as , cytochrome c is released from the into the , where it promotes activation and .

Integration with oxidative phosphorylation

ATP synthase and proton motive force

The , also known as Complex V of the mitochondrial electron transport chain, is a rotary embedded in the that harnesses the proton motive force (PMF) to synthesize ATP from ADP and inorganic phosphate (Pi). The PMF, consisting of the (Δψ) and gradient (ΔpH) across the membrane, provides the energy for this process, with protons flowing back into through the enzyme driving rotation and catalysis. Structurally, ATP synthase comprises two main domains: the membrane-embedded F0 portion, which includes a proton-translocating c-ring channel formed by 8–15 c-subunits (8 in mammalian mitochondria), and the peripheral F1 portion in , featuring a catalytic hexameric head of three α and three β subunits arranged as (αβ)3 around a central γ rotor stalk. The mechanism of ATP synthesis, elucidated by Paul Boyer's binding change model and confirmed by structural studies from John Walker, involves proton-driven rotation of the c-ring coupled to conformational changes in the F1 head. Protons enter the F0 channel via an a-subunit half-channel from the , bind to aspartate or glutamate residues on c-subunits, and drive stepwise rotation of the c-ring (45° per proton in mammalian mitochondria, or 8 protons per full 360° turn). This rotation turns the γ stalk, which induces sequential conformational shifts in the β-subunits: from open (O, nucleotide release), to loose (L, ADP/Pi binding), to tight (T, ATP formation without energy input), releasing one ATP per 120° rotation and thus three ATP per full turn. The overall reaction is ADP + Pi + n H⁺_out → ATP + n H⁺_in, where n reflects the proton . Stoichiometry links PMF utilization to ATP yield: in mammalian mitochondria, a c-ring of 8 subunits translocates 8 protons per full rotation for 3 ATP synthesized at the (mechanistic stoichiometry of ~2.67 H⁺/ATP). Accounting for additional protons required for ADP import and Pi uptake (~1 H⁺ each via translocators), the effective is ~4 H⁺/ATP overall. Combined with ~10 H⁺ pumped per NADH oxidized by the upstream complexes, this results in a P/O ratio of ~2.5 ATP per NADH (or ~1.5 per FADH₂, with 6 H⁺ pumped via Complexes II–IV). This efficiency ensures that the PMF, generated by electron transport, directly powers without net ATP hydrolysis under physiological conditions. Regulation of ATP synthase maintains cellular energy homeostasis and prevents wasteful ATP hydrolysis during low PMF states. The inhibitory factor 1 (IF1) binds to the F1 β-subunits in a pH- and Δp-dependent manner, stabilizing the enzyme in an inactive conformation to block hydrolysis while allowing synthesis when PMF is high. Oligomycin, a natural antibiotic, specifically inhibits proton translocation through the F0 c-ring by binding the a/c interface, halting both synthesis and hydrolysis. The enzyme's activity is thus finely tuned to the PMF magnitude, slowing rotation at low gradients. F-type ATP synthases exhibit remarkable evolutionary conservation across domains of life, with bacterial homologs like that in Escherichia coli (also featuring a 10-c-subunit ring) operating analogously to drive ATP synthesis using PMF from diverse respiratory chains. This conservation underscores their origin as ancient proton pumps adapted for energy conservation in membranes.

Reverse electron transport and ROS generation

Reverse electron transport (RET) refers to the backward flow of electrons within the mitochondrial electron transport chain, where reducing equivalents from (QH₂) are transferred to Complex I, reducing NAD⁺ to NADH against the typical gradient. This process is driven by a high proton motive force (), which provides the energy to overcome the endergonic nature of the reaction, particularly when the ubiquinone pool is highly reduced and NAD⁺ levels are elevated. The key reaction can be represented as: \ceQH2+NAD+−>Q+NADH+H+\ce{QH2 + NAD+ -> Q + NADH + H+} This thermodynamically unfavorable transfer (negative ΔE) is favored under conditions of high membrane potential and a reduced CoQ/CoQH₂ ratio, such as during succinate accumulation via Complex II. RET prominently occurs in pathophysiological states like ischemia-reperfusion injury, where succinate buildup from reversed Complex II activity fuels electron donation to the CoQ pool, promoting backward flow to Complex I. In such scenarios, RET accounts for a substantial portion of reactive oxygen species (ROS) production, with superoxide (O₂⁻) generated primarily at the flavin mononucleotide (FMN) site of Complex I during reverse electron entry. Additional ROS sites include the FMN site in forward mode and the Q₀ site of Complex III, where semiquinone intermediates leak electrons to molecular oxygen; overall, approximately 1-2% of electrons in the chain divert to O₂ under physiological conditions, escalating during RET. Physiologically, RET-mediated ROS signaling supports adaptive responses, such as hypoxic sensing in cells and immune activation in macrophages, where controlled bursts modulate pathways like HIF-1α stabilization. However, excessive RET-driven ROS contributes to oxidative damage in pathologies, including ischemia-reperfusion, by peroxidizing lipids and proteins. Antioxidants like (SOD) mitigate this by converting to , while targeted agents such as mitoQ accumulate in mitochondria to scavenge RET-derived ROS. Recent studies from the highlight RET's role in cancer metabolism, particularly in brain cancer stem cells of , where elevated RET at Complex I sustains , generates ROS for proliferation signaling, and maintains NAD⁺/NADH balance via activation, rendering these cells vulnerable to RET inhibitors like CPTP.

Prokaryotic electron transport chains

Diversity of electron donors and dehydrogenases

In prokaryotic electron transport chains (ETCs), the entry of electrons occurs through a diverse array of dehydrogenases that oxidize various substrates, enabling adaptation to different environmental conditions and energy demands. Unlike the more conserved mitochondrial systems, bacterial ETCs feature modular components that allow flexible assembly of respiratory modules, facilitating efficient under aerobic, microaerobic, or anaerobic growth. This modularity supports the integration of multiple electron donors into the quinone pool, enhancing metabolic versatility in diverse bacterial lineages. NADH serves as a primary in many , oxidized by two main types of NADH:quinone oxidoreductases. NDH-1, a complex I homolog, is a proton-pumping that translocates approximately 4 H⁺ per 2 electrons transferred from NADH to , contributing to the proton motive for ATP synthesis; it is prevalent in species like . In contrast, NDH-2 is a simpler, non-pumping single-subunit that transfers electrons from NADH to without generating a proton gradient, often serving as a backup or alternative pathway in organisms such as and . Beyond NADH, alternative dehydrogenases oxidize a range of organic and inorganic substrates to feed electrons into the ETC. For instance, formate dehydrogenase (FDH) catalyzes the oxidation of to CO₂, transferring electrons to , as exemplified by the reaction: HCOO−+Q→CO2+QH2\text{HCOO}^- + \text{Q} \rightarrow \text{CO}_2 + \text{QH}_2 This process is crucial for in E. coli and other enteric bacteria, where FDH enables utilization as an energy source. Similarly, and other substrate-specific enzymes provide additional entry points for electrons from products. Specialized dehydrogenases further expand substrate diversity, including those for gases like H₂ and CO. Hydrogenases, such as [NiFe]- or [FeFe]-types, oxidize molecular hydrogen (H₂ → 2H⁺ + 2e⁻) and channel electrons into the quinone pool or other carriers, supporting lithoautotrophic growth in like Ralstonia eutropha. dehydrogenase (CODH) oxidizes CO to CO₂, integrating this toxic gas as an energy source in carboxydotrophic prokaryotes such as Oligotropha carboxidovorans, thereby mitigating environmental CO while generating reducing equivalents. In certain marine and pathogenic bacteria, the Na⁺-translocating NADH:quinone reductase (Nqr) couples NADH oxidation to Na⁺ extrusion, pumping 2 Na⁺ per 2 electrons without proton translocation; this is prominent in Vibrio cholerae, where it establishes a sodium motive force for flagellar motility and solute transport under varying oxygen levels. Menaquinol-dependent dehydrogenases, often involved in anaerobic conditions, oxidize substrates using menaquinone as an intermediate, as seen in sulfate-reducing bacteria like Desulfovibrio vulgaris, allowing adaptation to low-potential environments. This diversity of dehydrogenases, through modular assembly, enables bacteria to thrive in microaerobic niches by optimizing electron flow and minimizing reactive oxygen species production.

Variations in quinones, cytochromes, and terminal oxidases

In prokaryotic electron transport chains (ETCs), quinones serve as mobile electron carriers that exhibit significant structural and functional variations to accommodate diverse environmental conditions. Ubiquinone (coenzyme Q), predominant in aerobic respiration, possesses a high midpoint (E°' ≈ +100 mV), facilitating efficient to oxygen under oxic conditions. In contrast, menaquinone () is the primary quinone in anaerobic or microaerobic environments, characterized by a lower (E°' ≈ -74 to -80 mV), which enables coupling to low-potential electron donors and acceptors such as fumarate or . Demethylmenaquinone, a structurally related variant, also features a low (E°' ≈ -36 mV) and participates in anaerobic branches of the ETC, particularly in like , where all three quinones coexist and influence pathway branching by directing electrons to specific downstream complexes based on redox poise and oxygen availability. Cytochrome variations further diversify prokaryotic ETCs, with the bc₁ complex (analogous to mitochondrial complex III) oxidizing low-potential quinols like menaquinol and transferring electrons to higher-potential c-type , thereby contributing to proton translocation via the Q-cycle mechanism. Alternative pathways bypass , utilizing bd-type quinol oxidases, which directly oxidize or menaquinol without an intervening and exhibit high affinity for oxygen (K_m ≈ 1-10 nM), allowing respiration under low-oxygen conditions. These bd oxidases, found exclusively in prokaryotes, are particularly vital in for survival during or hypoxia. Terminal oxidases represent the most variable downstream components, adapting to oxygen levels, altitude, or alternative acceptors. The aa₃-type , resembling eukaryotic complex IV, couples quinol or oxidation to oxygen reduction while pumping protons (2 H⁺/2 e⁻). In contrast, the ba₃-type , prevalent in high-altitude or microaerophilic such as Thermus thermophilus, operates with lower proton-pumping (≈1 H⁺/2 e⁻) but higher oxygen affinity, suited for low-oxygen niches. For in anaerobic like Pseudomonas stutzeri, nitric oxide reductases serve as terminal enzymes, reducing NO to N₂O as part of the respiratory chain, integrating with upstream quinone-dependent branches. A representative reaction for bd-type oxidases illustrates this adaptability: QH₂ + ½ O₂ → Q + H₂O, accompanied by proton translocation of 2 H⁺/2 e⁻ across the via vectorial quinol oxidation, without active pumping. These variations enable branching in prokaryotic ETCs, as exemplified in E. coli, where cytochrome bo₃ (an aa₃-like quinol ) handles high-oxygen aerobic respiration, while alternative bd oxidases or menaquinone-linked paths activate under low oxygen, optimizing energy yield and survival across gradients.

Examples from aerobic and anaerobic bacteria

In aerobic bacteria, Escherichia coli exemplifies a flexible electron transport chain adapted to varying oxygen levels, featuring two NADH dehydrogenases—NDH-1, a proton-pumping complex I homolog, and NDH-2, a non-proton-pumping —and two terminal quinol oxidases: bo₃, which operates under high oxygen conditions with high proton-pumping efficiency, and bd, which predominates in microaerobic environments for its lower oxygen affinity. This switching mechanism optimizes energy yield while protecting against , with NDH-1 and bo₃ contributing to higher ATP production under normoxia. Similarly, Paracoccus denitrificans possesses a mitochondrial-like respiratory chain, including a canonical complex I (NDH-1), ubiquinone, complex III, , and a terminal aa₃-type oxidase, enabling efficient aerobic respiration with a proton motive force comparable to eukaryotic mitochondria. This configuration supports high ATP yields through , and the bacterium's branched chain allows adaptation to alternative electron acceptors like under oxygen limitation, though aerobic conditions maximize efficiency. Facultative anaerobes like demonstrate branched electron transport with multiple terminal oxidases for environmental versatility, including the quinol oxidase cytochrome aa₃, which pumps protons efficiently under aerobic conditions, and cyanide-resistant cytochrome bd, which sustains respiration in low-oxygen or toxin-exposed settings. The presence of a cytochrome c oxidase branch alongside quinol oxidases allows B. subtilis to balance energy production and stress tolerance, with aa₃ handling bulk oxygen reduction and bd providing a protective, alternative pathway. In strict anaerobes such as species, the electron transport chain couples or oxidation to sulfate reduction via menaquinone (MK-6), involving transmembrane complexes like Qrc (quinone-reducing complex) and Dsr (dissimilatory sulfite reductase) without oxygen involvement, generating a modest proton motive force for ATP synthesis. This menaquinone-dependent pathway supports in sulfate-rich, anoxic environments, though it yields fewer protons translocated per electron compared to aerobic chains. Methanogenic , such as those in the genus , employ a unique anaerobic electron transport system where reduced coenzyme F₄₂₀ (F₄₂₀H₂) donates electrons to heterodisulfide reductase (Hdr), forming a proton-translocating complex that reduces the CoM-S-S-CoB heterodisulfide to thiols during from CO₂ and H₂. This F₄₂₀H₂:Hdr pathway generates a proton gradient for but operates without quinones or typical of bacterial respiration, highlighting archaeal divergence. Unique adaptations in prokaryotic chains include the role of cytochrome bd oxidases in respiratory protection, where they act as oxygen scavengers to shield or other O₂-sensitive enzymes in microaerophilic or transitioning , consuming trace oxygen without generating excessive . Recent metagenomic studies from the 2020s have uncovered uncultured prokaryotic diversity, revealing novel electron transport configurations in environmental microbiomes, such as expanded variants in sediment communities that expand known respiratory plasticity. Efficiency varies markedly, with aerobic chains like those in E. coli and P. denitrificans yielding up to 30-38 ATP per glucose equivalent through extensive proton pumping, whereas anaerobic systems in Desulfovibrio and methanogens produce far less—typically 1-5 ATP per reduced substrate—prioritizing and survival in electron acceptor-limited niches over maximal energy harvest.

Photosynthetic electron transport chains

Oxygenic photosynthesis in chloroplasts

In oxygenic photosynthesis, the electron transport chain (ETC) in chloroplasts of , , and converts light energy into by driving non-cyclic electron flow from to NADP⁺, producing oxygen as a byproduct. This process occurs within the membranes and involves two linked by the b₆f complex, forming the Z-scheme. The Z-scheme, first proposed in 1960, illustrates the sequential excitation of electrons at higher redox potentials in (PSII) and (PSI), enabling efficient energy capture despite the thermodynamic barrier between the two systems. The primary components include PSII, PSI, the mobile carrier plastoquinone (PQ), the cytochrome b₆f complex, and plastocyanin (PC). PSII, centered around the reaction core chlorophyll pair P680, contains the oxygen-evolving complex (OEC) with a Mn₄CaO₅ cluster that catalyzes water oxidation to extract electrons. Electrons from the OEC pass through a pheophytin-quinone (Q_A-Q_B) acceptor complex, where Q_B binds PQ to form plastoquinol (PQH₂). The cytochrome b₆f complex, homologous to complex III in respiration, features b-type hemes, a Rieske iron-sulfur protein, and cytochrome f, facilitating electron transfer from PQH₂ to PC via a Q-cycle mechanism. PSI, with its P700 reaction center chlorophyll pair, includes iron-sulfur (Fe-S) clusters (F_X, F_A, F_B) that relay electrons to soluble ferredoxin (Fd), which reduces NADP⁺ to NADPH via ferredoxin-NADP⁺ reductase. Linear electron flow follows the path: H₂O → PSII (P680) → PQ → cytochrome b₆f → PC → PSI (P700) → Fd → NADP⁺. Light absorption at PSII boosts electrons from P680 to pheophytin, creating P680⁺, which oxidizes the OEC to split (2H₂O → O₂ + 4H⁺ + 4e⁻). These electrons reduce PQ to PQH₂, which diffuses to cytochrome b₆f. There, the Q-cycle bifurcates electrons: one to PC via the Rieske center and cytochrome f, and the other across the membrane to reduce another PQ molecule, amplifying proton translocation. PC then delivers electrons to P700⁺ in PSI, where light re-energizes them to reduce Fd and ultimately NADP⁺. A parallel cyclic electron flow around PSI returns electrons from Fd to cytochrome b₆f via ferredoxin-dependent pathways, enhancing ATP production without NADPH generation. Proton pumping builds a proton motive force (ΔpH) across the thylakoid membrane, essential for ATP synthesis. In PSII, oxidation releases scalar protons (4H⁺ per O₂) into the lumen. The b₆f Q-cycle translocates 4H⁺ per 2e⁻ (2 from PQH₂ scalar release in the lumen and 2 vectorial from the stromal to lumen side), contributing the majority of the gradient. This ΔpH, along with a minor , drives to produce ATP from ADP and Pᵢ. The overall Z-scheme stoichiometry for linear flow is 2H₂O + 2NADP⁺ + ~8 photons → O₂ + 2NADPH + 2H⁺, balancing NADPH and ATP needs for the , though cyclic flow adjusts the ATP/NADPH ratio. Unique to chloroplast thylakoids, the photosynthetic ETC enables dynamic regulation through state transitions and (). State transitions involve reversible of II (LHCII) proteins, mediated by the state of PQ; in state 1 (oxidized PQ), LHCII associates with PSII, while in state 2 (reduced PQ), ~15% of LHCII migrates to PSI via actin-dependent mechanisms, balancing excitation between . dissipates excess light energy as heat in LHCII antennae, primarily through pH-dependent formation and PsbS protein activation in PSII, preventing photodamage under high light. These mechanisms optimize electron flow and protect the chain in varying light conditions. Recent structural studies using cryo-electron microscopy have advanced understanding of the photosynthetic ETC's assembly and regulation. For instance, a 2024 study achieved a 1.7 Å resolution structure of PSII, revealing intricate water channels involved in substrate delivery to the OEC. In 2022, the PSI–NDH supercomplex was resolved at high resolution, elucidating cyclic electron flow mechanisms. Additionally, 2023 cryo-EM structures of LHCII in photo-active and photo-protecting states demonstrated of energy dissipation. These findings highlight the dynamic supramolecular organization that optimizes efficiency under fluctuating light conditions.

Anoxygenic photosynthesis in bacteria

Anoxygenic photosynthesis in involves electron transport chains that utilize light energy to generate a proton motive force for ATP synthesis without producing oxygen, relying instead on alternative electron donors such as reduced compounds. These processes occur in diverse prokaryotes, primarily and green sulfur bacteria, each employing distinct reaction centers and carriers. , such as those in the Rhodospirillaceae family, feature a Type II reaction center with a special pair P870 that absorbs light at approximately 870 nm, initiating to a (Q), followed by the bc1 complex, , and terminal oxidases like aa3 under aerobic conditions. In contrast, green sulfur bacteria utilize a Type I reaction center with P840, where light excitation drives electrons through iron-sulfur (Fe-S) centers to menaquinone, enabling oxidation without . Electron donors in these systems include hydrogen sulfide (H₂S), molecular hydrogen (H₂), and organic compounds, but notably exclude , which limits the process to anoxic environments. For instance, like Chromatium oxidize or H₂S to elemental or via enzymes such as :quinone (SQR), providing electrons to the quinone pool. Green similarly employ H₂S as a primary donor, oxidized by SQR to deposit granules outside the cell. The electron flow typically proceeds from the donor to the reaction , then through quinones or to terminal acceptors, often in a cyclic manner that returns electrons to the or reduces NAD⁺ for carbon fixation, thereby establishing a proton gradient across the for ATP production. A representative reaction in green is 2H2S+2Q→S0+2QH22\mathrm{H_2S} + 2\mathrm{Q} \rightarrow \mathrm{S_0} + 2\mathrm{QH_2}, where quinone accepts electrons from oxidation. Unique structural and functional aspects enhance the efficiency of these chains, including intracytoplasmic membranes in that invaginate from the cytoplasmic membrane to house reaction centers and light-harvesting complexes, optimizing light capture under low-oxygen conditions. These bacteria, exemplified by Rhodobacter capsulatus, demonstrate remarkable versatility, seamlessly switching between photosynthetic electron transport and respiratory modes by sharing components like the bc1 complex and quinones when oxygen becomes available. This homology between bacterial Type I and II reaction centers and eukaryotic I and II underscores their evolutionary conservation, though anoxygenic chains operate with a single .

Regulation, inhibitors, and pathology

Mechanisms of regulation

The electron transport chain (ETC) is regulated at multiple levels to fine-tune mitochondrial respiration according to cellular energy demands, preventing excessive (ROS) production and maintaining metabolic . Allosteric mechanisms provide rapid, reversible control by sensing immediate metabolic states, while post-translational modifications allow dynamic adjustments to environmental cues like . Transcriptional adapts the ETC composition over longer timescales in response to hypoxia or oxygen availability, and structural dynamics of supercomplexes influence electron flux efficiency. In both eukaryotic and prokaryotic systems, these layers integrate with signaling to coordinate overall . Allosteric regulation directly modulates ETC complex activities based on energy status. In mammalian mitochondria, cytochrome c oxidase (Complex IV) is inhibited by ATP binding to its matrix domain under high-energy conditions, reducing electron flux and preserving a low to minimize ROS generation. This ATP-mediated inhibition is particularly pronounced in the phosphorylated, dimeric form of Complex IV, ensuring respiratory control without complete shutdown. Similarly, Complex I activity is allosterically inhibited by a high NADH/NAD⁺ ratio, which reflects substrate accumulation and prevents over-reduction of the chain, thereby linking upstream metabolic states to downstream rates. Post-translational modifications offer precise, covalent control over ETC function, often in response to signaling pathways or stress. of Complex I subunits by (PKA), activated via cAMP signaling, alters its assembly, catalytic activity, and supercomplex integration, thereby governing kinetics and oxygen consumption in response to hormonal or adrenergic stimuli. S-glutathionylation, a reversible modification, protects ETC complexes from oxidative damage during ROS elevation; for instance, it targets Complex I and Complex II to attenuate production by blocking electron leakage, while also feeding back to adjust nutrient uptake and mitochondrial . These modifications enable the ETC to adapt swiftly to imbalances without requiring new protein synthesis. Transcriptional control reshapes the ETC proteome to match environmental conditions, particularly oxygen levels. In hypoxic mammalian cells, hypoxia-inducible factor 1 (HIF-1) suppresses and promotes isoform switching in Complex IV, such as upregulating COX4-2 expression while downregulating COX4-1 via LON protease, optimizing respiratory efficiency and reducing oxygen consumption. In , the ArcA/ArcB two-component system senses state to regulate genes; under low oxygen, phosphorylated ArcA activates transcription of cytochrome bd (cydAB) for microaerobic respiration while repressing aerobic cytochrome bo , ensuring adaptive to available acceptors. Supercomplex dynamics further regulate ETC efficiency through assembly and disassembly, stabilizing electron channeling. In mitochondria, factors like COX7A2L (SCAF1) promote the association of Complexes I, III, and IV into respirasomes, enhancing proton pumping and reducing ROS by minimizing diffusible intermediate exposure; disruptions in these factors lead to disassembly and inefficient flux. Assembly of Complex IV itself relies on dedicated factors such as SCO1 and SURF1, which coordinate subunit incorporation and supercomplex integration to maintain structural integrity under varying metabolic loads. Calcium signaling provides an additional layer of , particularly in mitochondria, where MICU1 acts as a gatekeeper for the mitochondrial calcium uniporter (MCU). By sensing cytosolic Ca²⁺ levels, MICU1 modulates Ca²⁺ influx to activate dehydrogenases like and α-ketoglutarate dehydrogenase, thereby stimulating ETC substrate supply and NADH production without overload. In , two-component systems beyond ArcA/B, such as RegB/RegA in photosynthetic species, sense or light cues to regulate ETC components, integrating environmental signals with respiratory adaptation. These mechanisms collectively ensure the ETC responds dynamically to physiological needs across organisms.

Inhibitors and experimental tools

Inhibitors of the electron transport chain (ETC) are valuable pharmacological and genetic tools that target specific complexes to dissect their functions, measure electron flux, and model mitochondrial dysfunction in settings. These agents bind to distinct sites within the complexes, blocking or proton translocation, and have been instrumental in elucidating the mechanistic details of . For instance, partial inhibition of Complex I by certain compounds can mimic physiological stress and inform therapeutic strategies. For Complex I (NADH:ubiquinone oxidoreductase), binds to the quinone-binding site (Q-site) in the domain, preventing from the iron-sulfur clusters to ubiquinone and halting NADH oxidation. Piericidin A similarly inhibits at the Q-site, competing with ubiquinone for binding and blocking the reduction step.47496-8/fulltext) is extensively used in cellular and animal models of , where chronic exposure induces selective loss by promoting mitochondrial (ROS) production and α-synuclein aggregation. Complex III (cytochrome bc1 complex) inhibitors target the Q-cycle, a bifurcated pathway. Antimycin A binds to the Qi site on the distal side, inhibiting from heme bH to ubiquinone and causing semiquinone accumulation at the Qo site, which facilitates ROS generation. Myxothiazol, in contrast, binds to the Qo site on the proximal side, blocking electron donation from the Rieske iron-sulfur protein to c1 and preventing initial oxidation; this specificity has been crucial for experimentally isolating Q-cycle branches. Complex IV () is inhibited by , which binds tightly to the heme a3 iron in the binuclear center, preventing oxygen binding and reduction to . targets the CuB site adjacent to heme a3, similarly disrupting the by competing with oxygen.45888-5/fulltext) (CO) serves as a spectroscopic tool, reversibly binding to heme a3 to probe the enzyme's state and interactions in low-temperature studies without permanent inactivation. Complex II (succinate:ubiquinone ) is targeted by thenoyltrifluoroacetone (TTFA), which binds to the ubiquinone reduction site in subunit C (Sdha), inhibiting succinate oxidation and flavin-mediated to ubiquinone. For (Complex V), occludes the FO proton channel, blocking proton flow through the c-ring and preventing ATP synthesis while allowing proton leak in some contexts. Genetic tools complement pharmacological inhibitors for ETC studies. (RNAi) knockouts silence nuclear-encoded ETC genes, enabling assessment of complex assembly and compensatory responses in cell lines. (mtDNA)-deficient rho0 cells, generated by treatment, lack mtDNA-encoded subunits and serve as models for ETC impairment, as they exhibit reduced respiration and reliance on . Flux assays, such as those using the XF analyzer, quantify oxygen consumption rate (OCR) to measure ETC activity; inhibitors like and are applied sequentially to isolate contributions from individual complexes via changes in basal, ATP-linked, and maximal respiration. Therapeutically, metformin acts as a partial Complex I inhibitor by binding near the Q-site, modestly reducing NADH oxidation to activate (AMPK) and improve insulin sensitivity in management. In the , proteolysis-targeting chimeras (PROTACs) have emerged as tools for targeted degradation of ETC complexes, such as Complex I subunits, by recruiting E3 ligases for ubiquitin-mediated proteolysis, offering spatiotemporal control in research beyond traditional small-molecule inhibition.

Role in diseases and cellular dysfunction

Dysfunction in the electron transport chain (ETC) is a hallmark of various mitochondrial diseases, primarily arising from in nuclear or that impair respiratory complexes. Leigh syndrome, a severe neurometabolic disorder, often results from defects in Complex I (NADH:ubiquinone oxidoreductase) or Complex IV (cytochrome c oxidase), leading to due to disrupted and energy failure in high-demand tissues like the . These , accounting for about one-third of childhood-onset cases, cause bilateral symmetric lesions in the and , manifesting as psychomotor regression, , and seizures. Similarly, (LHON) stems from primary in Complex I genes, such as MT-ND1, MT-ND4, and MT-ND6, resulting in acute or subacute vision loss from degeneration. These point disrupt , reducing ATP production and triggering retinal ganglion cell . In neurodegenerative disorders, ETC impairments contribute to selective neuronal vulnerability. Parkinson's disease features a specific Complex I deficiency in the , where neurons degenerate, leading to motor symptoms like bradykinesia and rigidity. This defect, observed in postmortem tissue, reduces NADH oxidation and elevates (ROS), exacerbating α-synuclein aggregation and neuronal loss. In , Complex IV activity declines in affected brain regions, partly due to amyloid-β peptide binding and inhibition of , which impairs energy metabolism and promotes . This bioenergetic failure correlates with amyloid plaque formation and cognitive decline, as amyloid-β oligomers further suppress mitochondrial respiration. Cancer cells exploit ETC alterations to favor proliferation, exemplified by the effect, where tumors suppress in favor of aerobic , even in oxygen-rich environments, to generate biosynthetic intermediates. Mutations in (Complex II), such as in SDHB or SDHD genes, cause succinate accumulation, mimicking hypoxia (pseudohypoxia) by stabilizing HIF-1α and driving and in paragangliomas and pheochromocytomas. This oncometabolite inhibits α-ketoglutarate-dependent dioxygenases, leading to epigenetic changes that promote tumorigenesis. ETC dysfunction also drives ROS-mediated pathologies. In aging, somatic mitochondrial DNA mutations accumulate due to chronic ROS exposure from leaky electron transport, impairing respiratory efficiency and accelerating in post-mitotic tissues. This vicious cycle of and oxidative damage contributes to frailty and organ decline without necessarily increasing overall ROS levels. During ischemia-reperfusion , such as in or , reverse electron transport at Complex I generates a burst of ROS upon oxygen restoration, fueled by succinate oxidation, exacerbating tissue damage through and . Emerging therapies in the 2020s target these defects, including EPI-743, a redox-active analog that bypasses CoQ10 deficiencies in ETC disorders by enhancing NADPH-dependent antioxidant defenses and stabilizing mitochondrial function in and related conditions. Gene editing approaches, such as base editors delivered via adeno-associated viruses, have corrected pathogenic mtDNA mutations in Complex I genes in patient-derived cells, restoring ETC activity and offering potential for treating LHON and . These interventions aim to mitigate and neurodegeneration by directly repairing heteroplasmic mutations.

References

  1. https://www.ncbi.nlm.nih.gov/books/NBK526105/
  2. https://www.ncbi.nlm.nih.gov/books/NBK26904/
  3. https://www.ncbi.nlm.nih.gov/books/NBK9861/
  4. https://pmc.ncbi.nlm.nih.gov/articles/PMC7545035/
  5. https://askabiologist.asu.edu/photosynthesis
  6. https://pmc.ncbi.nlm.nih.gov/articles/PMC8786287/
  7. https://www.nobelprize.org/prizes/medicine/1931/warburg/biographical/
  8. https://royalsocietypublishing.org/doi/10.1098/rspb.1925.0039
  9. https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1469-185X.1951.tb01205.x
  10. https://pubmed.ncbi.nlm.nih.gov/17446142/
  11. https://www.jbc.org/article/S0021-9258%2820%2970795-7/pdf
  12. https://www.nobelprize.org/uploads/2018/06/mitchell-lecture.pdf
  13. https://link.springer.com/article/10.1007/s40828-019-0085-4
  14. https://www.sciencedirect.com/science/article/pii/S221323172030879X
  15. https://book.bionumbers.org/what-is-the-redox-potential-of-a-cell/
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC3093832/
  17. https://pmc.ncbi.nlm.nih.gov/articles/PMC7767752/
  18. https://www.sciencedirect.com/topics/immunology-and-microbiology/mitochondrial-membrane-potential
  19. https://pmc.ncbi.nlm.nih.gov/articles/PMC4706149/
  20. https://www.science.org/doi/10.1126/sciadv.abj3221
  21. https://www.pnas.org/doi/10.1073/pnas.1510577112
  22. https://www.pnas.org/doi/10.1073/pnas.0711249105
  23. https://www.science.org/doi/10.1126/science.abc4209
  24. https://portlandpress.com/biochemj/article/480/5/319/232763/From-the-black-box-to-domino-effect-mechanism-what
  25. https://www.embopress.org/doi/10.1038/emboj.2012.300
  26. https://www.pnas.org/doi/10.1073/pnas.2216713120
  27. https://pubs.acs.org/doi/10.1021/bi401630m
  28. https://journals.asm.org/doi/10.1128/jb.184.19.5339-5347.2002
  29. https://www.sciencedirect.com/topics/nursing-and-health-professions/ubiquinone
  30. https://www.nature.com/articles/s41574-023-00926-0
  31. https://pmc.ncbi.nlm.nih.gov/articles/PMC2578832/
  32. https://febs.onlinelibrary.wiley.com/doi/10.1111/febs.16164
  33. https://pmc.ncbi.nlm.nih.gov/articles/PMC3101715/
  34. https://journals.physiology.org/doi/full/10.1152/physrev.00006.2014
  35. https://www.nature.com/articles/s41422-018-0071-1
  36. https://pmc.ncbi.nlm.nih.gov/articles/PMC3262112/
  37. https://pubs.acs.org/doi/10.1021/acs.chemrev.7b00664
  38. https://www.sciencedirect.com/science/article/pii/S0005272818300422
  39. https://pmc.ncbi.nlm.nih.gov/articles/PMC3132828/
  40. https://pmc.ncbi.nlm.nih.gov/articles/PMC7931083/
  41. https://pubmed.ncbi.nlm.nih.gov/11239484/
  42. https://faseb.onlinelibrary.wiley.com/doi/full/10.1096/fj.06-6644com
  43. https://journals.physiology.org/doi/full/10.1152/physrev.00015.2003
  44. https://lpi.oregonstate.edu/mic/dietary-factors/coenzyme-Q10
  45. https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/ubiquinone
  46. https://pmc.ncbi.nlm.nih.gov/articles/PMC4112531/
  47. https://pmc.ncbi.nlm.nih.gov/articles/PMC2446998/
  48. https://www.sciencedirect.com/science/article/pii/S0005272809000796
  49. https://pmc.ncbi.nlm.nih.gov/articles/PMC2684812/
  50. https://pmc.ncbi.nlm.nih.gov/articles/PMC3075374/
  51. https://www.nature.com/articles/4401950
  52. https://www.annualreviews.org/doi/10.1146/annurev-biochem-013118-110903
  53. https://www.nobelprize.org/prizes/chemistry/1997/press-release/
  54. https://pmc.ncbi.nlm.nih.gov/articles/PMC2947903/
  55. https://pmc.ncbi.nlm.nih.gov/articles/PMC10722325/
  56. https://www.sciencedirect.com/science/article/pii/S1550413108001721
  57. https://pmc.ncbi.nlm.nih.gov/articles/PMC5486155/
  58. https://pmc.ncbi.nlm.nih.gov/articles/PMC6559295/
  59. https://pmc.ncbi.nlm.nih.gov/articles/PMC8852348/
  60. https://pmc.ncbi.nlm.nih.gov/articles/PMC4463002/
  61. https://pmc.ncbi.nlm.nih.gov/articles/PMC539002/
  62. https://pmc.ncbi.nlm.nih.gov/articles/PMC6513898/
  63. https://pmc.ncbi.nlm.nih.gov/articles/PMC3438948/
  64. https://www.nature.com/articles/s41586-023-05781-7
  65. https://pmc.ncbi.nlm.nih.gov/articles/PMC11942997/
  66. https://www.nature.com/articles/s41467-022-31718-1
  67. https://pmc.ncbi.nlm.nih.gov/articles/PMC8509429/
  68. https://pmc.ncbi.nlm.nih.gov/articles/PMC2761819/
  69. https://proteopedia.org/wiki/index.php/Cytochrome_bd_oxidase
  70. https://www.pnas.org/doi/pdf/10.1073/pnas.1108217108
  71. https://pubs.acs.org/doi/10.1021/bi00230a019
  72. https://.ncbi.nlm.nih.gov/8491720/
  73. https://pmc.ncbi.nlm.nih.gov/articles/PMC6955949/
  74. https://link.springer.com/chapter/10.1007/978-94-011-5133-7_6
  75. https://journals.asm.org/doi/10.1128/mbio.00823-16
  76. https://pubmed.ncbi.nlm.nih.gov/8388393/
  77. https://www.sciencedirect.com/science/article/pii/S2211546313000144
  78. https://pmc.ncbi.nlm.nih.gov/articles/PMC3911205/
  79. https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2011.00135/full
  80. https://www.pnas.org/doi/pdf/10.1073/pnas.87.23.9449
  81. https://pmc.ncbi.nlm.nih.gov/articles/PMC55183/
  82. https://pmc.ncbi.nlm.nih.gov/articles/PMC3171616/
  83. https://www.nature.com/articles/srep27631
  84. https://www.microbiologyresearch.org/content/journal/mgen/10.1099/mgen.0.000853
  85. https://pmc.ncbi.nlm.nih.gov/articles/PMC4215793/
  86. https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2018.01322/full
  87. https://www.pnas.org/doi/10.1073/pnas.1219922110
  88. https://www.nature.com/articles/s41477-024-01804-x
  89. https://www.nature.com/articles/s41467-021-22502-8
  90. https://www.pnas.org/doi/10.1073/pnas.1103659108
  91. https://www.pnas.org/doi/10.1073/pnas.97.26.14283
  92. https://www.pnas.org/doi/10.1073/pnas.1319164111
  93. https://www.pnas.org/doi/10.1073/pnas.1211017109
  94. https://www.nature.com/articles/s41580-025-00847-y
  95. https://pmc.ncbi.nlm.nih.gov/articles/PMC2238716/
  96. https://pmc.ncbi.nlm.nih.gov/articles/PMC11269200/
  97. https://pmc.ncbi.nlm.nih.gov/articles/PMC8224592/
  98. https://www.embopress.org/doi/full/10.1038/msb4100191
  99. https://pmc.ncbi.nlm.nih.gov/articles/PMC7714679/
  100. https://pmc.ncbi.nlm.nih.gov/articles/PMC11940177/
  101. https://pmc.ncbi.nlm.nih.gov/articles/PMC4235479/
  102. https://www.ncbi.nlm.nih.gov/books/NBK482499/
  103. https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-024-11060-0
  104. https://pubmed.ncbi.nlm.nih.gov/2154550/
  105. https://www.nature.com/articles/s41392-022-00983-3
  106. https://pmc.ncbi.nlm.nih.gov/articles/PMC3087417/
  107. https://www.pnas.org/doi/10.1073/pnas.0705738104
  108. https://pmc.ncbi.nlm.nih.gov/articles/PMC4783224/
  109. https://pmc.ncbi.nlm.nih.gov/articles/PMC12033202/
  110. https://erc.bioscientifica.com/view/journals/erc/27/12/ERC-20-0346.xml
  111. https://pmc.ncbi.nlm.nih.gov/articles/PMC4237642/
  112. https://www.pnas.org/doi/10.1073/pnas.0508886102
  113. https://pmc.ncbi.nlm.nih.gov/articles/PMC10135819/
  114. https://www.sciencedirect.com/science/article/pii/S1096719211003787
  115. https://www.eurekalert.org/news-releases/1087554
  116. https://pmc.ncbi.nlm.nih.gov/articles/PMC12301291/
Add your contribution
Related Hubs
User Avatar
No comments yet.